Care pathways for the selection of a biologic in severe asthma

Affiliations

• ¹ Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France jean.bousquet@orange.fr.
• ² INSERM U 1168, VIMA: Ageing and chronic diseases Epidemiological and public health approaches, Villejuif, Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny le Bretonneux, France.
• ³ Euforea, Brussels, Belgium.
• ⁴ Dept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
• ⁵ Dept of Pulmonary Medicine, Mainz University Hospital, Mainz, Germany.
• ⁶ Division of Allergy, Pulmonary and Critical Care Medicine, Dept of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
• ⁷ ProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Brazil.
• ⁸ GARD Executive Committee, Brazil.
• ⁹ University Southampton Faculty of Medicine and NIHR Southampton Respiratory Biomedical Research Unit, Southampton, UK.
• ¹⁰ Pulmonary Service, Corporació Sanitària Parc Taulí, Dept of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
• ¹¹ Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, American Lung Association, Asthma Clinical Research Centers Network, Houston, TX, USA.
• ¹² Université Paris-Sud; Service de Pneumologie, Hôpital Bicêtre; Inserm UMR_S999, Le Kremlin Bicêtre, France.
• ¹³ Royal Brompton Hospital, London, UK.
• ¹⁴ Harvard Medical School, Division of Allergy and Immunology, Asthma Clinical Research Center, Boston Children's Hospital, Boston, MA, USA.
• ¹⁵ Pediatric Department, Charité, Berlin, Germany.
• ¹⁶ Dept of Pulmonary and Critical Care Medicine, National Jewish Health, Denver, CO, USA.